<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://72.32.98.217</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 03 Nov 2025 08:00:00 -0500</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://72.32.98.217</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>REX Shares Appoints Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Press+Releases/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</link>
   <description>
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative exchange-traded funds (ETFs), is pleased to announce the appointment of Matt Holcomb as Portfolio Manager for the REX IncomeMax™ Option Strategy ETF (Ticker: ULTI), which launched Friday. ULTI is a sophisticated, actively managed strategy designed to turn market volatility into weekly income by writing options on some of the most dynamic U.S. stocks.

&lt;/p&gt;&lt;p&gt;
Holcomb will oversee the fund’s active options strategy, managing exposure across a targeted portfolio that generally will contain 15 to 30 of the most volatile U.S. equities, but may have as few as five</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</guid>
   <pubDate>Mon, 03 Nov 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Appoints Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Press+Releases/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</link>
   <description>
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative exchange-traded funds (ETFs), is pleased to announce the appointment of Matt Holcomb as Portfolio Manager for the REX IncomeMax™ Option Strategy ETF (Ticker: ULTI), which launched Friday. ULTI is a sophisticated, actively managed strategy designed to turn market volatility into weekly income by writing options on some of the most dynamic U.S. stocks.

&lt;/p&gt;&lt;p&gt;
Holcomb will oversee the fund’s active options strategy, managing exposure across a targeted portfolio that generally will contain 15 to 30 of the most volatile U.S. equities, but may have as few as five</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</guid>
   <pubDate>Mon, 03 Nov 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Appoints Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Press+Releases/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</link>
   <description>
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative exchange-traded funds (ETFs), is pleased to announce the appointment of Matt Holcomb as Portfolio Manager for the REX IncomeMax™ Option Strategy ETF (Ticker: ULTI), which launched Friday. ULTI is a sophisticated, actively managed strategy designed to turn market volatility into weekly income by writing options on some of the most dynamic U.S. stocks.

&lt;/p&gt;&lt;p&gt;
Holcomb will oversee the fund’s active options strategy, managing exposure across a targeted portfolio that generally will contain 15 to 30 of the most volatile U.S. equities, but may have as few as five</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</guid>
   <pubDate>Mon, 03 Nov 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Appoints Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Business+Wire/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</link>
   <description>
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative exchange-traded funds (ETFs), is pleased to announce the appointment of Matt Holcomb as Portfolio Manager for the REX IncomeMax™ Option Strategy ETF (Ticker: ULTI), which launched Friday. ULTI is a sophisticated, actively managed strategy designed to turn market volatility into weekly income by writing options on some of the most dynamic U.S. stocks.

&lt;/p&gt;&lt;p&gt;
Holcomb will oversee the fund’s active options strategy, managing exposure across a targeted portfolio that generally will contain 15 to 30 of the most volatile U.S. equities, but may have as few as five</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</guid>
   <pubDate>Mon, 03 Nov 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Appoints Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Business+Wire/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</link>
   <description>
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative exchange-traded funds (ETFs), is pleased to announce the appointment of Matt Holcomb as Portfolio Manager for the REX IncomeMax™ Option Strategy ETF (Ticker: ULTI), which launched Friday. ULTI is a sophisticated, actively managed strategy designed to turn market volatility into weekly income by writing options on some of the most dynamic U.S. stocks.

&lt;/p&gt;&lt;p&gt;
Holcomb will oversee the fund’s active options strategy, managing exposure across a targeted portfolio that generally will contain 15 to 30 of the most volatile U.S. equities, but may have as few as five</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</guid>
   <pubDate>Mon, 03 Nov 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Appoints Matt Holcomb as Portfolio Manager for REX IncomeMax™ Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Business+Wire/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</link>
   <description>
&lt;p&gt;    NEW YORK--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative exchange-traded funds (ETFs), is pleased to announce the appointment of Matt Holcomb as Portfolio Manager for the REX IncomeMax™ Option Strategy ETF (Ticker: ULTI), which launched Friday. ULTI is a sophisticated, actively managed strategy designed to turn market volatility into weekly income by writing options on some of the most dynamic U.S. stocks.

&lt;/p&gt;&lt;p&gt;
Holcomb will oversee the fund’s active options strategy, managing exposure across a targeted portfolio that generally will contain 15 to 30 of the most volatile U.S. equities, but may have as few as five</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/REX+Shares+Appoints+Matt+Holcomb+as+Portfolio+Manager+for+REX+IncomeMax%E2%84%A2+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25542471.html</guid>
   <pubDate>Mon, 03 Nov 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Launches REX IncomeMax Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</link>
   <description>
&lt;p&gt;    MIAMI--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX IncomeMax Option Strategy ETF (Ticker: ULTI), an actively managed fund designed to capture weekly income by monetizing market volatility.

&lt;/p&gt;&lt;p&gt;
The ULTI is a sophisticated strategy targeting the market’s most volatile U.S. stocks with an options strategy that dynamically adjusts to changing market conditions. ULTI seeks to turn volatility into weekly income while managing risk through active positioning.

&lt;/p&gt;&lt;p&gt;
The portfolio typically holds 20 to 30 volatile U.S. equities, with the investment team actively managing exposures and option positioning as volatility and market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</guid>
   <pubDate>Fri, 31 Oct 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Launches REX IncomeMax Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</link>
   <description>
&lt;p&gt;    MIAMI--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX IncomeMax Option Strategy ETF (Ticker: ULTI), an actively managed fund designed to capture weekly income by monetizing market volatility.

&lt;/p&gt;&lt;p&gt;
The ULTI is a sophisticated strategy targeting the market’s most volatile U.S. stocks with an options strategy that dynamically adjusts to changing market conditions. ULTI seeks to turn volatility into weekly income while managing risk through active positioning.

&lt;/p&gt;&lt;p&gt;
The portfolio typically holds 20 to 30 volatile U.S. equities, with the investment team actively managing exposures and option positioning as volatility and market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</guid>
   <pubDate>Fri, 31 Oct 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Launches REX IncomeMax Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</link>
   <description>
&lt;p&gt;    MIAMI--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX IncomeMax Option Strategy ETF (Ticker: ULTI), an actively managed fund designed to capture weekly income by monetizing market volatility.

&lt;/p&gt;&lt;p&gt;
The ULTI is a sophisticated strategy targeting the market’s most volatile U.S. stocks with an options strategy that dynamically adjusts to changing market conditions. ULTI seeks to turn volatility into weekly income while managing risk through active positioning.

&lt;/p&gt;&lt;p&gt;
The portfolio typically holds 20 to 30 volatile U.S. equities, with the investment team actively managing exposures and option positioning as volatility and market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</guid>
   <pubDate>Fri, 31 Oct 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Launches REX IncomeMax Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</link>
   <description>
&lt;p&gt;    MIAMI--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX IncomeMax Option Strategy ETF (Ticker: ULTI), an actively managed fund designed to capture weekly income by monetizing market volatility.

&lt;/p&gt;&lt;p&gt;
The ULTI is a sophisticated strategy targeting the market’s most volatile U.S. stocks with an options strategy that dynamically adjusts to changing market conditions. ULTI seeks to turn volatility into weekly income while managing risk through active positioning.

&lt;/p&gt;&lt;p&gt;
The portfolio typically holds 20 to 30 volatile U.S. equities, with the investment team actively managing exposures and option positioning as volatility and market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</guid>
   <pubDate>Fri, 31 Oct 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Launches REX IncomeMax Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</link>
   <description>
&lt;p&gt;    MIAMI--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX IncomeMax Option Strategy ETF (Ticker: ULTI), an actively managed fund designed to capture weekly income by monetizing market volatility.

&lt;/p&gt;&lt;p&gt;
The ULTI is a sophisticated strategy targeting the market’s most volatile U.S. stocks with an options strategy that dynamically adjusts to changing market conditions. ULTI seeks to turn volatility into weekly income while managing risk through active positioning.

&lt;/p&gt;&lt;p&gt;
The portfolio typically holds 20 to 30 volatile U.S. equities, with the investment team actively managing exposures and option positioning as volatility and market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</guid>
   <pubDate>Fri, 31 Oct 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>REX Shares Launches REX IncomeMax Option Strategy ETF (Ticker: ULTI)</title>
   <link>http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</link>
   <description>
&lt;p&gt;    MIAMI--(BUSINESS WIRE)--
REX Shares (“REX”), a leading innovator in alternative ETFs, today announced the launch of the REX IncomeMax Option Strategy ETF (Ticker: ULTI), an actively managed fund designed to capture weekly income by monetizing market volatility.

&lt;/p&gt;&lt;p&gt;
The ULTI is a sophisticated strategy targeting the market’s most volatile U.S. stocks with an options strategy that dynamically adjusts to changing market conditions. ULTI seeks to turn volatility into weekly income while managing risk through active positioning.

&lt;/p&gt;&lt;p&gt;
The portfolio typically holds 20 to 30 volatile U.S. equities, with the investment team actively managing exposures and option positioning as volatility and market</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/REX+Shares+Launches+REX+IncomeMax+Option+Strategy+ETF+%28Ticker%3A+ULTI%29/25534064.html</guid>
   <pubDate>Fri, 31 Oct 2025 08:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19134880</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00416607</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Announces New UV1 Data Showing Enhanced Efficacy Including in Hard-to-Treat Cancer Patients, Supporting Broad Utility</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/1018/20711668.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Announces+New+UV1+Data+Showing+Enhanced+Efficacy+Including+in+Hard-to-Treat+Cancer+Patients%2C+Supporting+Broad+Utility/20711668.html</guid>
   <pubDate>Tue, 18 Oct 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial  of UV1 in Malignant Melanoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0630/20275702.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</guid>
   <pubDate>Thu, 30 Jun 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial  of UV1 in Malignant Melanoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0630/20275702.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</guid>
   <pubDate>Thu, 30 Jun 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial  of UV1 in Malignant Melanoma</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0630/20275702.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</guid>
   <pubDate>Thu, 30 Jun 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial  of UV1 in Malignant Melanoma</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0630/20275702.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Ultimovacs+Completes+Patient+Recruitment+in+INITIUM+Phase+II+Trial++of+UV1+in+Malignant+Melanoma/20275702.html</guid>
   <pubDate>Thu, 30 Jun 2022 02:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.10975030</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
  <item>
   <title>Ultimovacs Hosting Key Opinion Leader Webinar on the Evolving Treatment Landscape of Melanoma</title>
   <link>http://www.streetinsider.com/Press+Releases/Ultimovacs+Hosting+Key+Opinion+Leader+Webinar+on+the+Evolving+Treatment+Landscape+of+Melanoma/19799273.html</link>
   <description>si-local-file:///var/storage/newsbody/2022/0321/19799273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Ultimovacs+Hosting+Key+Opinion+Leader+Webinar+on+the+Evolving+Treatment+Landscape+of+Melanoma/19799273.html</guid>
   <pubDate>Mon, 21 Mar 2022 03:00:00 -0500</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.21045924</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.41659699</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ULTI</category>
   	  </item>
 </channel>
</rss>
